Boston Scientific Corporation (NYSE:BSX) agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy ...

ANSWER: Whether stents are beneficial in people with stable coronary artery disease remains somewhat controversial. Although ...

A study has revealed a significant link between a common pregnancy complication and early heart disease in women. The study ...

A discussion with Campbell Rogers, MD, regarding advances in AI technology for prevention and management of coronary artery disease.

CathWorks has completed the enrolment for a randomised controlled trial (RCT), evaluating the FFRangio system in diagnosing ...

The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...

Boston Scientific has agreed to acquire the rest of Bolt Medical, the developer of an intravascular-lithotripsy, or IVL, laser-based platform for the treatment of coronary and peripheral artery ...

While genetics play a role in heart disease risk, lifestyle modifications can significantly influence outcomes. Individuals ...